Medicare Enrolled
Dr. Paul Gerczuk, MD
Cardiovascular Disease · Tampa, FL
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gerczuk from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gerczuk? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gerczuk
Dr. Paul Gerczuk is a cardiovascular disease in Tampa, FL, with 16 years in practice. Based on federal Medicare data, Dr. Gerczuk performed 5,866 Medicare services across 3,508 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gerczuk received a total of $48,827 from 50 pharmaceutical and/or device companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gerczuk is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice▲ Top 17% volume in FL$ $48,827 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,866
Medicare services
Top 17% in FL for cardiovascular disease
3,508
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~367 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 796 | $93 | $273 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 495 | $27 | $93 |
| Hospital follow-up visit, moderate complexity | 472 | $62 | $186 |
| Remote pacemaker/defibrillator monitoring, 90 days | 397 | $16 | $62 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 313 | $20 | $68 |
| Electrocardiogram (EKG), 12-lead | 296 | $11 | $43 |
| New patient office visit (45-59 min) | 291 | $125 | $415 |
| Remote pacemaker monitoring, 90 days | 282 | $23 | $79 |
| Regadenoson injection (Lexiscan) for heart stress test | 236 | $41 | $144 |
| Echocardiogram, transthoracic | 193 | $139 | $510 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 184 | $18 | $68 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 179 | $340 | $897 |
| Programming of dual lead pacemaker system | 144 | $57 | $162 |
| Initial hospital admission, high complexity | 141 | $137 | $516 |
| Evaluation of implantable heart and blood vessel monitoring system | 131 | $33 | $105 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 117 | $28 | $113 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 89 | $321 | $1,178 |
| Ultrasound of heart with probe in esophagus, with report | 87 | $83 | $280 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 87 | $2 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 84 | $14 | $47 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 82 | $778 | $3,059 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 79 | $46 | $177 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 79 | $251 | $1,158 |
| Hospital follow-up visit, high complexity | 46 | $94 | $265 |
| Repair of left upper heart chamber with implant with review by radiologist | 44 | $633 | $2,152 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 40 | $55 | $365 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 38 | $9 | $37 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 38 | $18 | $62 |
| Initial hospital admission, moderate complexity | 37 | $100 | $350 |
| Insertion of implantable defibrillator system | 36 | $737 | $2,479 |
| Programming of dual lead implantable defibrillator system | 35 | $74 | $212 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 33 | $251 | $1,160 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $413 | $1,408 |
| Heart rhythm recording of continous external ekg over 8-15 days | 28 | $9 | $37 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 28 | $19 | $68 |
| Programming of multiple lead implantable defibrillator system | 27 | $79 | $230 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 26 | $19 | $67 |
| External shock to heart to regulate heart beat | 25 | $82 | $401 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 22 | $620 | $1,713 |
| Insertion of heart rhythm monitor under skin | 19 | $3,251 | $12,549 |
| Removal and replacement of dual lead permanent pacemaker | 17 | $287 | $950 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 16 | $380 | $1,279 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 14 | $686 | $2,279 |
| Programming of heart rhythm stimulation after drug infusion | 11 | $65 | $429 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.4% high complexity
9.1% medium
63.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$48,827
Total received (2018-2024)
Avg $6,975/year across 7 years
Top 8% in FL for cardiovascular disease
50
Companies
702
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,691 (48.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,232 (31.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,904 (20.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,679
2023$10,898
2022$4,116
2021$3,903
2020$3,124
2019$8,249
2018$12,858
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$10,789
BIOTRONIK INC.
$6,791
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$5,400
Abbott Laboratories
$5,256
Medtronic Vascular, Inc.
$4,972
Medtronic, Inc.
$2,701
ATRICURE, INC.
$2,315
Aziyo Biologics, Inc.
$1,924
Biosense Webster, Inc.
$1,833
Impulse Dynamics (USA) Inc.
$979
AtriCure, Inc.
$760
SANOFI-AVENTIS U.S. LLC
$654
Medical Device Business Services, Inc.
$640
E.R. Squibb & Sons, L.L.C.
$631
Acutus Medical, Inc.
$464
PFIZER INC.
$459
Novartis Pharmaceuticals Corporation
$379
Janssen Pharmaceuticals, Inc
$324
BOSTON SCIENTIFIC CORPORATION
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
AstraZeneca Pharmaceuticals LP
$155
Esperion Therapeutics, Inc.
$125
CVRx, Inc.
$102
Kestra Medical Technology Services, Inc.
$67
Invuity, Inc.
$67
Regeneron Healthcare Solutions, Inc.
$54
iRhythm Technologies, Inc.
$51
Volta Medical Inc
$49
Amgen Inc.
$49
Merck Sharp & Dohme Corporation
$37
CARDIVA MEDICAL, INC.
$36
Preventice Services, LLC
$29
Elutia, Inc.
$28
ABBVIE INC.
$27
Biom'Up France SAS
$26
Actelion Pharmaceuticals US, Inc.
$25
Terumo Medical Corporation
$21
Philips North America LLC
$18
Amarin Pharma Inc.
$18
AltaThera Pharmaceuticals LLC
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
CORDIS US CORP.
$16
Edwards Lifesciences Corporation
$16
MEDICOMP INC
$14
Gilead Sciences, Inc.
$12
Kiniksa Pharmaceuticals, Ltd.
$11
G Medical Diagnostic Services, Inc.
$11
Allergan Inc.
$11
Bardy Diagnostics, Inc.
$3
Top 3 companies account for 47.1% of total payments
Associated products mentioned in payments ›
(CK7) Extended Holter · AFFERA MAPPING SYSTEM · AMPLATZER AMULET · AMVIA EDGE · ANDEXXA · ARCTIC FRONT ADVANCE · ARTIC-L 3D TI SPINAL SYSTEM WITH TIONIC TECHNOLOGY · ARTiC-L · ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM · AVEIR · Acticor · Advisor Catheter · Arctic Front · Assure WCD · Assurity Pacemaker · Azure · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor 2 · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CELEBREX · CHANTIX · CLINICAL TRIAL PRODUCT · COMET · CONFIRM RX · Cardiac Mapping System · Cardiac Monitor · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Carto 3 · Carto 3 System · CartoSound · Cobalt · Confirm Rx · Corlanor · DIAMONDBACK CORONARY · DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER · ECM Patch · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYS · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora · Edwards SAPIEN 3 Transcatheter Heart Valve · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Evera · FARXIGA · FINELINE II Sterox · FLEXCATH ADVANCE · Fortify Assura · GENERAL EP · GENERAL THERAPIES · GENERAL - BRADY · GENERAL - THERAPIES · GENERAL STRUCTURAL HEART · GENERAL TACHY · HEMOBLAST BELLOWS · INGEVITY · JARDIANCE · JOT DX · LATITUDE · LEQVIO · LINQ II · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MULTAQ · Micra · Mynx Venous VCD · NEXLIZET · OCTARAY MAPPING CATHETER · OPSUMIT · OPTIMIZER · OptiSense Pacing Lead · Optimizer · Optimizer Smart System · PAMIRA · PRADAXA · PRALUENT · PULSESELECT · Pacemakers · Photonblade · Pouch · Quadra Assura CRT Defibrillator · RESONATE · RESONATE EL ICD VR · REVEAL LINQ · RHYTHMIA · Renamic Neo · Repatha · Reveal LINQ · S ICD · SELECTSECURE · SKYRIZI · SYNERGY ABLATION SYSTEM · Solia · Sotalol Hydrochloride · TRULANCE · VADO · VERQUVO · VISIONIST · VX1 · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (48%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for cardiovascular disease in FL.
Equivalent to $832 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
225
Per 100K population
15.1
County median income
$75,011
Nearest hospital
ADVENTHEALTH TAMPA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Gerczuk is a remote & electrophysiology specialist, with above-average Medicare volume (top 17% in FL), and high industry engagement (mixed engagement, top 8%), with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Gerczuk experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gerczuk performed 796 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gerczuk receive payments from pharmaceutical companies?
Yes. Dr. Gerczuk received a total of $48,827 from 50 companies across 702 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gerczuk's costs compare to other cardiovascular diseases in Tampa?
Dr. Gerczuk's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gerczuk) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Tampa
Browse cardiovascular diseases in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC..
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology